Ruff

• In this role, Dr. Stavenhagen will lead the Company’s discovery and preclinical research and translational science initiatives.
• “I’m thrilled to welcome Jeff to the Dianthus team as we advance next-generation antibody therapeutics for patients living with severe autoimmune diseases.
• He was most recently Chief Scientific Officer at Therini Bio, where he directed R&D initiatives leading to the development of a first-in-class monoclonal antibody for the treatment of neurodegenerative diseases.
• She earned a master’s degree in biotechnology from Northwestern University and a bachelor’s degree in biology from the University of Iowa.

• NEW YORK, Nov. 14, 2023 /PRNewswire/ -- The Eagle Academy Foundation (EAF), renowned for its commitment to the education and success of young men of color in New York City and beyond, announces its second annual Career Pathways Expo on Friday, November 17, from 11 am-3 pm.
• This impactful event welcomes high school juniors and seniors to explore a wide array of industries and career opportunities, particularly in fields where people of color are underrepresented.
• More than 1500 students from NYC Public Schools will have the chance to connect with over 40 exhibitors, gaining insights into diverse career paths and employment opportunities.
• The Career Pathways Expo is a signature event of the Eagles Soaring Beyond (ESB) program, which seeks to empower young men of color to define success on their terms and excel by creating multiple pathways to success after high school graduation.

• Johnson passed away on Oct. 28 after being cut in the neck by another player’s skate blade during a professional hockey game in Sheffield, England.
• Understandably, a vigorous debate has ensued about whether neck guards should be made mandatory beyond the minor hockey league level.
• Some leagues quickly responded by implementing neck guard policies and others might follow once the issue has been filtered through the proper channels.

Lasting impacts of traumatic events

• This practice can damage athletes when they’re confronted with traumatic events, which are more frequent than many realize.
• I have spent the last four years exploring team tragedy in the youth hockey context.
• They didn’t want to appear as “damaged goods,” particularly when they were so close to their childhood NHL dreams.
• Some players managed to sublimate their mental struggles while their hockey career lasted, but many experienced a significant, if delayed, reckoning in their late 30s.

Hope on the horizon

• Recent troubling incidents involving Hockey Canada prove more can, and must, be done to improve the hockey experience.
• Nevertheless, our interviews with youth hockey stakeholders demonstrate there is a clear desire to better support teams struck by tragedy.
• What remains elusive, however, is an emergency plan that youth hockey organizations can implement once tragedy occurs.

Supporting player mental health

• The money provided by Hockey Canada’s insurance for grief counselling is capped at $1,000 per team, which doesn’t go far in our inflationary times.
• Minor hockey associations that operate in the not-for-profit space and rely heavily on volunteers are particularly shorthanded.
• A recent change in leadership and direction shows Hockey Canada is serious about winning back the trust of the public.

Craig Greenham receives funding from the Social Sciences and Humanities Research Council.

• This news comes just days after it was announced that the AZALEA-TIMI 71 study was stopped early by the independent Data Monitoring Committee (DMC) due to an overwhelming greater-than-anticipated reduction in major and clinically relevant non-major bleeds in abelacimab compared to rivaroxaban and a benefit/risk profile also favoring abelacimab.
• A Fast-Track Designation for abelacimab was previously granted by the U.S. Food and Drug Administration (FDA) for the prevention of stroke and systemic embolism in patients with atrial fibrillation.
• “This additional positive news further recognizes the confidence that Anthos Therapeutics placed early-on in the development program of abelacimab.
• The results of the AZALEA-TIMI 71 study firmly establishes that thrombosis can successfully be uncoupled from hemostasis,” said John Glasspool, CEO, Anthos Therapeutics.